Community Health Systems 2026 UBS Global Healthcare Conference
Review the key takeaways and the transcript of this earnings call.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Oh. There you go. All right, I think we'll get started on the next presentation. We're very pleased to have Community Health Systems with us today. Kevin Hammons, Chief Executive Officer, and Jason Johnson, Chief Financial Officer. At this point, we're 10 and a half, 11 months into the year. When you think back on what we've seen so far, what have been the bright spots? What have been the challenges? Any thoughts on that, maybe to start off?
Sure. Happy to jump in here. Coming into the year, knew there was a few headwinds out there, but did not expect some of the economic headwinds to be persistent as they were. We didn't anticipate the disruption in the Middle East to have such an impact on us and the economy, certainly with the price of gas. We didn't expect the exchange and the expiration of the enhanced premium tax credits to have as big of an impact as it has. As we sit here today, I think we've all experienced bigger impacts from that, more headwinds than we anticipated. The economy in particular, which I think has been about a half the drag on us this year, there's a lot of pent-up demand. I think a lot of that's just going to be timing, and we'll see that business come back to us.
Okay. On that last point, one of the other companies, Ardent, I think, was talking about that they have traced that people are getting the prescriptions. They're going to see the doctor, they're getting the diagnostics, and they're getting referred to the surgery, but then they're not doing it.
Yeah. Do you guys see that?
Very much so. We've had almost an 8% increase in our clinic visits. Patients are going to the doctor or their specialist. We have seen an increase in orthopedic MRIs, an increase in other screening procedures, far outpacing prior year. But it's not translating into the surgery at the same rate. Now, we are seeing the trans-- For the government-insured patients, we're still seeing them come in for surgeries, but they don't have a copay and deductible to worry about to the same extent that the commercial insurance patients do. That again leads us to believe that this is more of an economic decision on the patient's part and why it's being deferred.
Okay. There's been some discussion about, well, maybe if people have traded down from silver to bronze, maybe if in their traditional commercial there's a higher copay this year, that we'll get into the fourth quarter and we'll start to see people hit those limits and then try to scramble to get to care before January 1st. I don't know whether you can even trace that. Do you have scheduling or anything that says that any of that's happening or not?
Historically, we've seen the fourth quarter, that seasonality- Yeah if you will, of people getting care in the back half of the year as they've hit their deductible.
I think once you get to the fourth quarter, if you haven't hit your deductible yet, you're not going to rush in and get something done just to hit your deductible and then have it reset again. We did not see the pickup in that commercial business beginning in the third quarter like you normally do with seasonality. So, we've taken that into consideration in terms of our updated guidance that we won't see the same level of seasonal pickup in Q4 as we normally do. We're expecting it to be deferred into next year.
Okay. Obviously, one thing I have to ask you about right up front is the events of the last week, the midterms. How do you view that outcome as it relates to Community Health Systems? Are there particular areas of optimism or pessimism with how you expect the new Congress to act?
I think it is a little early to tell yet. The election probably went a little farther than some folks had expected in terms of outcomes. That said, incoming Speaker Jeffries has already indicated that top of their list of priorities is to restore the enhanced premium tax credits, and also to either delay or get rid of some of the Medicaid cuts from the One Big Beautiful Bill. So, that does appear to be kind of some top priority items for the incoming Democrats in Congress. I do think there will be some negotiations and compromise at the executive level, and likely that some of that will go through.
I think the structure of the One Big Beautiful Bill with delayed cuts to begin with and were not scheduled to start till 2028, which is going to be another election cycle, and then phasing those in over 10 years, it was unlikely that those cuts ever went into full effect anyways, giving themselves an opportunity on the Republican side to probably delay or defer some of those cuts to begin with. So, even now with a change in congressional leadership, I think it is more likely that that may be accelerated some anyways.
Okay. Your overall volume held up pretty well in 3Q, but the mix was a bit tougher. Do you want to just describe for people what you are seeing, and is that pretty much what you are expecting and has continued into the fourth quarter?
Sure. What we're seeing is a bigger impact on the reduction in HIX patients coming in as uninsured. Pretty significant portion of the increase in ER visits have all been uninsured patients. Likewise, almost half of our adjusted admission increase in the third quarter were uninsured patients. I think we're capturing business. We're, I think, picking up market share, as I'd indicated, almost an 8% increase in physician clinic visits during the quarter. Patients are still coming to see us. It's the higher acuity services that's really been a drag on margin and kind of the top line growth.
When they defer that surgery, as we talked about before, with the visits and the imaging that's being done, and people need it, can you hold onto that patient, or is that patient at risk generally of maybe down the road, for some reason, you won't get that procedure? Is there any indication of how long some of those types of procedures can be delayed?
I think a patient who defers care is always up or in play, so to speak, the capture. In this particular situation with disruption across the market, some of the work that we're doing is a system to improve our quality, improve our physician experience, improve our patient experience, some of the top priorities we've really been investing in. I think that actually becomes an opportunity for us because patients and our competitors are also deferring care. We believe that we have an opportunity to capture more of that and hold onto our own patients, but also maybe capture more of the patients who are outside of our system when they decide to come back for care.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.
View the full transcript with ProCall participants
3 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
